help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Asa, S. L.
Right arrow Articles by Elsholtz, H. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Asa, S. L.
Right arrow Articles by Elsholtz, H. P.

Journal of Clinical Endocrinology & Metabolism, Vol 77, 1275-1280, Copyright © 1993 by Endocrine Society


ARTICLES

Cell type-specific expression of the pituitary transcription activator pit-1 in the human pituitary and pituitary adenomas

SL Asa, LA Puy, AM Lew, VC Sundmark and HP Elsholtz
Department of Pathology, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.

Pit-1 is a transcription factor that has been shown to be critical for pituitary-specific activation of the GH and PRL genes. In rodents and humans, differentiation and/or maintenance of somatotroph, lactotroph, and thyrotroph phenotypes are dependent on expression of a functional pit-1 gene. In rodents, Pit-1 protein is detectable in only these three cell types; however, pit-1 mRNA transcripts appear to be present at comparable levels in all adenohypophysial cell types, suggesting that translational controls may dictate the pattern of Pit-1 expression. We examined the distribution of pit-1 transcripts in the human pituitary and pituitary adenomas. All tumors were characterized by immunocytochemistry, electron microscopy, and tissue culture for accurate classification. Northern blot analysis demonstrated abundant levels of pit-1 mRNA in somatotroph, mammosomatotroph, and lactotroph adenomas. Two clinically silent adenomas that expressed TSH as well as gonadotropins contained detectable levels of pit-1 mRNA. No pit-1 expression was otherwise detected in corticotroph, gonadotroph, null cell, or oncocytic adenomas. In situ hybridization localized pit-1 mRNA transcripts in adenomas that contained GH, PRL, or TSH, but not in adenomas composed of other cell types. Pit-1 mRNA was also localized to selected subpopulations of the human nontumorous adenohypophysis that contained immunoreactivity for GH, PRL, and/or TSH. Pit-1 protein immunoreactivity was detected in the nuclei of adenomas that expressed pit-1 mRNA, but not in those that were negative for pit-1 mRNA; it was also localized only in cells containing GH, PRL, or TSH beta in the nontumorous adenohypophysis. These data demonstrate selective expression of the human pit-1 gene in adenohypophysial cell types responsible for GH, PRL, and/or TSH synthesis and are consistent with a predominantly pretranslational regulatory mechanism for Pit-1 expression in the human.


This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
P. Peixoto, Y. Liu, S. Depauw, M.-P. Hildebrand, D. W. Boykin, C. Bailly, W. D. Wilson, and M.-H. David-Cordonnier
Direct inhibition of the DNA-binding activity of POU transcription factors Pit-1 and Brn-3 by selective binding of a phenyl-furan-benzimidazole dication
Nucleic Acids Res., June 1, 2008; 36(10): 3341 - 3353.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
N Y Y Al-Brahim and S L Asa
My approach to pathology of the pituitary gland
J. Clin. Pathol., December 1, 2006; 59(12): 1245 - 1253.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
S. Seoane and R. Perez-Fernandez
The Vitamin D Receptor Represses Transcription of the Pituitary Transcription Factor Pit-1 Gene without Involvement of the Retinoid X Receptor
Mol. Endocrinol., April 1, 2006; 20(4): 735 - 748.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
R. Y. Osamura, S. Tahara, R. Kurotani, N. Sanno, A. Matsuno, and A. Teramoto
Contributions of Immunohistochemistry and In Situ Hybridization to the Functional Analysis of Pituitary Adenomas
J. Histochem. Cytochem., April 1, 2000; 48(4): 445 - 458.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
Y. Nakamura, T. Usui, H. Mizuta, H. Murabe, S. Muro, M. Suda, K. Tanaka, I. Tanaka, A. Shimatsu, and K. Nakao
Characterization of Prophet of Pit-1 Gene Expression in Normal Pituitary and Pituitary Adenomas in Humans
J. Clin. Endocrinol. Metab., April 1, 1999; 84(4): 1414 - 1419.
[Abstract] [Full Text]


Home page
Endocr. Rev.Home page
S. L. Asa and S. Ezzat
The Cytogenesis and Pathogenesis of Pituitary Adenomas
Endocr. Rev., December 1, 1998; 19(6): 798 - 827.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
I. M. Bennani-Baiti, S. L. Asa, D. Song, R. Iratni, S. A. Liebhaber, and N. E. Cooke
DNase I-hypersensitive sites I and II of the human growth hormone locus control region are a major developmental activator of somatotrope gene expression
PNAS, September 1, 1998; 95(18): 10655 - 10660.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. T. Schanke, C. M. Conwell, M. Durning, J. M. Fisher, and T. G. Golos
Pit-1/Growth Hormone Factor 1 Splice Variant Expression in the Rhesus Monkey Pituitary Gland and the Rhesus and Human Placenta
J. Clin. Endocrinol. Metab., March 1, 1997; 82(3): 800 - 807.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1993 by The Endocrine Society